364 results on '"Ahlsson, Anders"'
Search Results
2. Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry
- Author
-
Skibniewski, Mikolaj, Venetsanos, Dimitrios, Ahlsson, Anders, Batra, Gorav, Friberg, Örjan, Hofmann, Robin, Janzon, Magnus, Karlsson, Lars O, Lawesson, Sofia Sederholm, Nielsen, Susanne J., Jeppsson, Anders, and Alfredsson, Joakim
- Published
- 2023
- Full Text
- View/download PDF
3. Impact of national holidays and weekends on incidence of acute type A aortic dissection repair
- Author
-
Oudin, Anna, Bjursten, Henrik, Oudin Åström, Daniel, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Moeller, Christian H., Jormalainen, Mikko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, and Zindovic, Igor
- Published
- 2022
- Full Text
- View/download PDF
4. Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study
- Author
-
Piccini, Jonathan P., Ahlsson, Anders, Dorian, Paul, Gillinov, Marc A., Kowey, Peter R., Mack, Michael J., Milano, Carmelo A., Perrault, Louis P., Steinberg, Jonathan S., Waldron, Nathan H., Adams, Lawrence M., Bharucha, David B., Brin, Mitchell F., Ferguson, William G., and Benussi, Stefano
- Published
- 2022
- Full Text
- View/download PDF
5. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation
- Author
-
Piccini, Jonathan P., primary, Ahlsson, Anders, additional, Dorian, Paul, additional, Gillinov, A. Marc, additional, Kowey, Peter R., additional, Mack, Michael J., additional, Milano, Carmelo A., additional, Noiseux, Nicolas, additional, Perrault, Louis P., additional, Ryan, William, additional, Steinberg, Jonathan S., additional, Voisine, Pierre, additional, Waldron, Nathan H., additional, Gleason, Kevin J., additional, Titanji, Wilson, additional, Leaback, Richard D., additional, O’Sullivan, Alexandra, additional, Ferguson, William G., additional, Benussi, Stefano, additional, Akhter, Shuhab A., additional, Andreas, Martin, additional, Castella, Manuel, additional, Dalrymple-Hay, Malcolm, additional, El-Eshmawi, Ahmed, additional, Groh, Mark, additional, Hanke, Thorsten, additional, Jeanmart, Hugues, additional, Katz, Marc, additional, McCullough, Jock N., additional, Melby, Spencer, additional, Miller, Jeffrey, additional, Romano, Matthew A., additional, Piccini, Jonathan P., additional, Podgoreanu, Mihai Victor, additional, Sharma, Vikas, additional, Shults, Christian, additional, Teman, Nicholas, additional, Whitson, Bryan A., additional, Wickbom, Anders, additional, Vallabhajosyula, Prashanth, additional, and Yau, Terrence, additional
- Published
- 2024
- Full Text
- View/download PDF
6. The contribution of intermittent handheld electrocardiogram and continuous electrocardiogram monitoring with an implantable loop recorder to detect incident and recurrent atrial fibrillation during 1 year after coronary artery bypass graft surgery: A prospective cohort study
- Author
-
Sandgren, Emma, Wickbom, Anders, Kalm, Torbjörn, Ahlsson, Anders, Edvardsson, Nils, and Engdahl, Johan
- Published
- 2021
- Full Text
- View/download PDF
7. Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study
- Author
-
Wickbom, Anders, Fengsrud, Espen, Alfredsson, Joakim, Engdahl, Johan, Kalm, Torbjoern, Ahlsson, Anders, Wickbom, Anders, Fengsrud, Espen, Alfredsson, Joakim, Engdahl, Johan, Kalm, Torbjoern, and Ahlsson, Anders
- Abstract
Objectives. Atrial fibrillation is a common arrhythmia in patients with ischemic heart disease. This study aimed to determine the cumulative incidence of new-onset atrial fibrillation after percutaneous coronary intervention or coronary artery bypass grafting surgery during 30 days of follow-up. Design. This was a prospective multi-center cohort study on atrial fibrillation incidence following percutaneous coronary intervention or coronary artery bypass grafting for stable angina or non-ST-elevation acute coronary syndrome. Heart rhythm was monitored for 30 days postoperatively by in-hospital telemetry and handheld thumb ECG recordings after discharge were performed. The primary endpoint was the cumulative incidence of atrial fibrillation 30 days after the index procedure. Results. In-hospital atrial fibrillation occurred in 60/123 (49%) coronary artery bypass graft and 0/123 percutaneous coronary intervention patients (p < .001). The cumulative incidence of atrial fibrillation after 30 days was 56% (69/123) of patients undergoing coronary artery bypass grafting and 2% (3/123) of patients undergoing percutaneous coronary intervention (p < .001). CABG was a strong predictor for atrial fibrillation compared to PCI (OR 80.2, 95% CI 18.1-354.9, p < .001). Thromboembolic stroke occurred in-hospital in one coronary artery bypass graft patient unrelated to atrial fibrillation, and at 30 days in two additional patients, one in each group. There was no mortality. Conclusion. New-onset atrial fibrillation during 30 days of follow-up was rare after percutaneous coronary intervention but common after coronary artery bypass grafting. A prolonged uninterrupted heart rhythm monitoring strategy identified additional patients in both groups with new-onset atrial fibrillation after discharge., Funding Agencies|Research Committee of rebro University Hospital
- Published
- 2024
- Full Text
- View/download PDF
8. The significance of bicuspid aortic valve after surgery for acute type A aortic dissection
- Author
-
Mennander, Ari, Olsson, Christian, Jeppsson, Anders, Geirsson, Arnar, Hjortdal, Vibeke, Hansson, Emma C., Jarvela, Kati, Nozohoor, Shahab, Gunn, Jarmo, Ahlsson, Anders, and Gudbjartsson, Tomas
- Published
- 2020
- Full Text
- View/download PDF
9. In-hospital physiotherapy improves physical activity level after lung cancer surgery: a randomized controlled trial
- Author
-
Jonsson, Marcus, Hurtig-Wennlöf, Anita, Ahlsson, Anders, Vidlund, Mårten, Cao, Yang, and Westerdahl, Elisabeth
- Published
- 2019
- Full Text
- View/download PDF
10. Differential outcomes of open and clamp-on distal anastomosis techniques in acute type A aortic dissection
- Author
-
Geirsson, Arnar, Shioda, Kayoko, Olsson, Christian, Ahlsson, Anders, Gunn, Jarmo, Hansson, Emma C., Hjortdal, Vibeke, Jeppsson, Anders, Mennander, Ari, Wickbom, Anders, Zindovic, Igor, and Gudbjartsson, Tomas
- Published
- 2019
- Full Text
- View/download PDF
11. Malperfusion in acute type A aortic dissection: An update from the Nordic Consortium for Acute Type A Aortic Dissection
- Author
-
Zindovic, Igor, Gudbjartsson, Tomas, Ahlsson, Anders, Fuglsang, Simon, Gunn, Jarmo, Hansson, Emma C., Hjortdal, Vibeke, Järvelä, Kati, Jeppsson, Anders, Mennander, Ari, Olsson, Christian, Pan, Emily, Sjögren, Johan, Wickbom, Anders, Geirsson, Arnar, and Nozohoor, Shahab
- Published
- 2019
- Full Text
- View/download PDF
12. Validation of a handheld single‐lead ECG algorithm for atrial fibrillation detection after coronary revascularization
- Author
-
Skröder, Sofia, primary, Wickbom, Anders, additional, Björkenheim, Anna, additional, Ahlsson, Anders, additional, Poci, Dritan, additional, and Fengsrud, Espen, additional
- Published
- 2023
- Full Text
- View/download PDF
13. Type A Aortic Dissection Repair in Patients With Prior Cardiac Surgery
- Author
-
Bjurbom, Markus, primary, Olsson, Christian, additional, Geirsson, Arnar, additional, Gudbjartsson, Tomas, additional, Gunn, Jarmo, additional, Hansson, Emma C., additional, Hjortdal, Vibeke, additional, Jeppsson, Anders, additional, Mennander, Ari, additional, Ede, Jacob, additional, Zindovic, Igor, additional, Ahlsson, Anders, additional, Wickbom, Anders, additional, and Dalén, Magnus, additional
- Published
- 2023
- Full Text
- View/download PDF
14. Validation of a handheld single-lead ECG algorithm for atrial fibrillation detection after coronary revascularization
- Author
-
Skröder, Sofia, Wickbom, Anders, Björkenheim, Anna, Ahlsson, Anders, Poçi, Dritan, Fengsrud, Espen, Skröder, Sofia, Wickbom, Anders, Björkenheim, Anna, Ahlsson, Anders, Poçi, Dritan, and Fengsrud, Espen
- Abstract
BACKGROUND: Atrial fibrillation (AF) is a rapidly increasing global public health concern entailing a high risk for ischemic stroke that can largely be avoided with anticoagulation therapy. AF is often underdiagnosed and there is a need for a reliable method of detection in individuals with additional risk factors for stroke such as coronary artery disease. We aimed to validate an automatic rhythm interpretation algorithm in thumb ECG in subjects with recent coronary revascularization. METHODS: Thumb ECG, a patient-operated handheld single-lead ECG recording device with an automatic interpretation algorithm, was performed three times daily for a month after coronary revascularization and 2-week periods 3, 12, and 24 months post-procedure. The detection of AF by the automatic algorithm on subject and single-strip ECG level was compared to manual interpretation. RESULTS: 48,308 of 30 s thumb ECG recordings from 255 subjects (mean 212 ± 3.5 recordings per subject) were retrieved from a database (AF 47 subjects/655 recordings; non-AF 208 subjects/47,653 recordings). The algorithm sensitivity at subject level was 100%, specificity 11.2%, positive predictive value (PPV) 20.2%, and negative predictive value (NPV) 100%. At the single-strip ECG level, sensitivity was 87.6%, specificity 94.0%, PPV 16.8%, and NPV 99.8%. The most common reasons for false positive results were technical disturbance and frequent ectopic beats. CONCLUSIONS: The automatic interpretation algorithm in a handheld thumb ECG device can rule out AF in patients recently undergoing coronary revascularization with high accuracy, but manual confirmation is needed to confirm the diagnose of AF because of high false positive rates., Funding agency:Centre for Clinical Research and Education, Region Värmland
- Published
- 2023
- Full Text
- View/download PDF
15. Type A Aortic Dissection Repair in Patients With Prior Cardiac Surgery
- Author
-
Bjurbom, Markus, Olsson, Christian, Geirsson, Arnar, Gudbjartsson, Tomas, Gunn, Jarmo, Hansson, Emma C., Hjortdal, Vibeke, Jeppsson, Anders, Mennander, Ari, Ede, Jacob, Zindovic, Igor, Ahlsson, Anders, Wickbom, Anders, Dalén, Magnus, Bjurbom, Markus, Olsson, Christian, Geirsson, Arnar, Gudbjartsson, Tomas, Gunn, Jarmo, Hansson, Emma C., Hjortdal, Vibeke, Jeppsson, Anders, Mennander, Ari, Ede, Jacob, Zindovic, Igor, Ahlsson, Anders, Wickbom, Anders, and Dalén, Magnus
- Abstract
Background: Emergency surgery for acute type A aortic dissection in patients with previous cardiac surgery is controversial. This study aimed to evaluate the association between previous cardiac surgery and outcomes after surgery for acute type A aortic dissection, to appreciate whether emergency surgery can be offered with acceptable risks. Methods: All patients operated on for acute type A aortic dissection between 2005 and 2014 from the Nordic Consortium for Acute Type A Aortic Dissection database were eligible. Patients with previous cardiac surgery were compared with patients without previous cardiac surgery. Univariable and multivariable statistical analyses were performed to identify predictors of 30-day mortality and early major adverse events (a secondary composite endpoint comprising 30-day mortality, perioperative stroke, postoperative cardiac arrest, or de novo dialysis). Results: In all, 1159 patients were included, 40 (3.5%) with previous cardiac surgery. Patients with previous cardiac surgery had higher 30-day mortality (30% vs 17.8%, P = .049), worse medium-term survival (51.7% vs 71.2% at 5 years, log rank P = .020), and higher unadjusted prevalence of major adverse events (52.5% vs 35.7%, P = .030). In multivariable analysis, previous cardiac surgery was not associated with 30-day mortality (odds ratio 0.78; 95% CI, 0.30-2.07; P = .624) or major adverse events (odds ratio 1.07; 95% CI, 0.45-2.55, P = .879). Conclusions: Major adverse events after surgery for acute type A aortic dissection were more frequent in patients with previous cardiac surgery. Previous cardiac surgery itself was not an independent predictor for adverse events, although the small sample size precludes definite conclusions. Previous cardiac surgery should not deter from emergency surgery.
- Published
- 2023
16. Clinical Course of Postoperative Atrial Fibrillation After Cardiac Surgery and Long-term Outcome
- Author
-
Rezk, Mary, primary, Taha, Amar, additional, Nielsen, Susanne J., additional, Gudbjartsson, Tomas, additional, Bergfeldt, Lennart, additional, Ahlsson, Anders, additional, and Jeppsson, Anders, additional
- Published
- 2022
- Full Text
- View/download PDF
17. Temperature effects on incidence of surgery for acute type A aortic dissection in the Nordics
- Author
-
Oudin Åström, Daniel, primary, Bjursten, Henrik, additional, Oudin, Anna, additional, Nozohoor, Shahab, additional, Ahmad, Khalil, additional, Tang, Mariann, additional, Bjurbom, Markus, additional, Hansson, Emma C, additional, Jeppsson, Anders, additional, Holdflod Møller, Christian Joost, additional, Jormalainen, Miko, additional, Juvonen, Tatu, additional, Mennander, Ari, additional, Olsen, Peter S, additional, Olsson, Christian, additional, Ahlsson, Anders, additional, Pan, Emily, additional, Raivio, Peter, additional, Wickbom, Anders, additional, Sjögren, Johan, additional, Geirsson, Arnar, additional, Gudbjartsson, Tomas, additional, and Zindovic, Igor, additional
- Published
- 2022
- Full Text
- View/download PDF
18. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
- Author
-
Kotecha, Dipak, Breithardt, Günter, Camm, A John, Lip, Gregory Y H, Schotten, Ulrich, Ahlsson, Anders, Arnar, David, Atar, Dan, Auricchio, Angelo, Bax, Jeroen, Benussi, Stefano, Blomstrom-Lundqvist, Carina, Borggrefe, Martin, Boriani, Giuseppe, Brandes, Axel, Calkins, Hugh, Casadei, Barbara, Castellá, Manuel, Chua, Winnie, Crijns, Harry, Dobrev, Dobromir, Fabritz, Larissa, Feuring, Martin, Freedman, Ben, Gerth, Andrea, Goette, Andreas, Guasch, Eduard, Haase, Doreen, Hatem, Stephane, Haeusler, Karl Georg, Heidbuchel, Hein, Hendriks, Jeroen, Hunter, Craig, Kääb, Stefan, Kespohl, Stefanie, Landmesser, Ulf, Lane, Deirdre A, Lewalter, Thorsten, Mont, Lluís, Nabauer, Michael, Nielsen, Jens C, Oeff, Michael, Oldgren, Jonas, Oto, Ali, Pison, Laurent, Potpara, Tatjana, Ravens, Ursula, Richard-Lordereau, Isabelle, Rienstra, Michiel, Savelieva, Irina, Schnabel, Renate, Sinner, Moritz F, Sommer, Philipp, Themistoclakis, Sakis, Van Gelder, Isabelle C, Vardas, Panagiotis E, Verma, Atul, Wakili, Reza, Weber, Evelyn, Werring, David, Willems, Stephan, Ziegler, André, Hindricks, Gerhard, and Kirchhof, Paulus
- Published
- 2018
- Full Text
- View/download PDF
19. Hospital volumes and later year of operation correlates with better outcomes in acute Type A aortic dissection†
- Author
-
Geirsson, Arnar, Ahlsson, Anders, Franco-Cereceda, Anders, Fuglsang, Simon, Gunn, Jarmo, Hansson, Emma C, Hjortdal, Vibeke, Jarvela, Kati, Jeppsson, Anders, Mennander, Ari, Nozohoor, Shahab, Olsson, Christian, Pan, Emily, Wickbom, Anders, Zindovic, Igor, and Gudbjartsson, Tomas
- Published
- 2018
- Full Text
- View/download PDF
20. Outcome After Surgery for Acute Type A Aortic Dissection With or Without Primary Tear Resection
- Author
-
Uimonen, Mikko, primary, Olsson, Christian, additional, Jeppsson, Anders, additional, Geirsson, Arnar, additional, Chemtob, Raphaelle, additional, Khalil, Ahmad, additional, Hjortdal, Vibeke, additional, Hansson, Emma C., additional, Nozohoor, Shahab, additional, Zindovic, Igor, additional, Gunn, Jarmo, additional, Wickbom, Anders, additional, Ahlsson, Anders, additional, Gudbjartsson, Tomas, additional, and Mennander, Ari, additional
- Published
- 2022
- Full Text
- View/download PDF
21. Once after a full moon: acute type A aortic dissection and lunar phases
- Author
-
Bjursten, Henrik, Oudin Åström, Daniel, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Joost Holdflod Møller, Christian, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Oudin, Anna, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, Zindovic, Igor, Bjursten, Henrik, Oudin Åström, Daniel, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Joost Holdflod Møller, Christian, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Oudin, Anna, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, and Zindovic, Igor
- Abstract
OBJECTIVES: Acute type A aortic dissection (ATAAD) is a rare but severe condition, routinely treated with emergent cardiac surgery. Many surgeons have the notion that patients with ATAAD tend to come in clusters, but no studies have examined these observations. This investigation was undertaken to study the potential association between the lunar cycle and the incidence of ATAAD. METHODS: We collected information on 2995 patients who underwent ATAAD surgery at centres from the Nordic Consortium for Acute Type A Aortic Dissection collaboration. We cross-referenced the time of surgery with lunar phase using a case-crossover design with 2 different definitions of full moon (>99% illumination and the 7-day full moon period). RESULTS: The period when the moon was illuminated the most (99% definition) did not show any significant increase in incidence for ATAAD surgery. However, when the full moon period was compared with all other moon phases, it yielded a relative risk of 1.08 [95% confidence interval (CI) 1.00-1.17, P = 0.057] and, compared to waxing moon, only the relative risk was 1.11 (95% CI 1.01-1.23, P = 0.027). The peak incidence came 4-6 days after the moon was fully illuminated. CONCLUSIONS: This study found an overrepresentation of surgery for ATAAD during the full moon phase. The explanation for this is not known, but we speculate that sleep deprivation during full moon leads to a temporary increase in blood pressure, which in turn could trigger rupture of the aortic wall. While this finding is interesting, it needs to be corroborated and the clinical implications are debateable.
- Published
- 2022
- Full Text
- View/download PDF
22. Temperature effects on incidence of surgery for acute type A aortic dissection in the Nordics
- Author
-
Oudin Åström, Daniel, Bjursten, Henrik, Oudin, Anna, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Holdflod Møller, Christian Joost, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, Zindovic, Igor, Oudin Åström, Daniel, Bjursten, Henrik, Oudin, Anna, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Holdflod Møller, Christian Joost, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, and Zindovic, Igor
- Abstract
We aimed to investigate a hypothesised association between daily mean temperature and the risk of surgery for acute type A aortic dissection (ATAAD). For the period of 1 January 2005 until 31 December 2019, we collected daily data on mean temperatures and date of 2995 operations for ATAAD at 10 Nordic cities included in the Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD) collaboration. Using a two-stage time-series approach, we investigated the association between hot and cold temperatures relative to the optimal temperature and the rate of ATAAD repair in the selected cities. The relative risks (RRs) of cold temperatures (≤−5°C) and hot temperatures (≥21°C) compared to optimal temperature were 1.47 (95% CI: 0.72–2.99) and 1.43 (95% CI: 0.67–3.08), respectively. In line with previous studies, we observed increased risk at cold and hot temperatures. However, the observed associations were not statistically significant, thus only providing weak evidence of an association.
- Published
- 2022
- Full Text
- View/download PDF
23. Once after a full moon:acute type A aortic dissection and lunar phases
- Author
-
Bjursten, Henrik, Oudin Åström, Daniel, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Joost Holdflod Møller, Christian, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Oudin, Anna, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, Zindovic, Igor, Bjursten, Henrik, Oudin Åström, Daniel, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Joost Holdflod Møller, Christian, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Oudin, Anna, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, and Zindovic, Igor
- Abstract
OBJECTIVES: Acute type A aortic dissection (ATAAD) is a rare but severe condition, routinely treated with emergent cardiac surgery. Many surgeons have the notion that patients with ATAAD tend to come in clusters, but no studies have examined these observations. This investigation was undertaken to study the potential association between the lunar cycle and the incidence of ATAAD. METHODS: We collected information on 2995 patients who underwent ATAAD surgery at centres from the Nordic Consortium for Acute Type A Aortic Dissection collaboration. We cross-referenced the time of surgery with lunar phase using a case-crossover design with 2 different definitions of full moon (>99% illumination and the 7-day full moon period). RESULTS: The period when the moon was illuminated the most (99% definition) did not show any significant increase in incidence for ATAAD surgery. However, when the full moon period was compared with all other moon phases, it yielded a relative risk of 1.08 [95% confidence interval (CI) 1.00-1.17, P = 0.057] and, compared to waxing moon, only the relative risk was 1.11 (95% CI 1.01-1.23, P = 0.027). The peak incidence came 4-6 days after the moon was fully illuminated. CONCLUSIONS: This study found an overrepresentation of surgery for ATAAD during the full moon phase. The explanation for this is not known, but we speculate that sleep deprivation during full moon leads to a temporary increase in blood pressure, which in turn could trigger rupture of the aortic wall. While this finding is interesting, it needs to be corroborated and the clinical implications are debateable.
- Published
- 2022
24. Temperature effects on incidence of surgery for acute type A aortic dissection in the Nordics
- Author
-
Åström, Daniel Oudin, Bjursten, Henrik, Oudin, Anna, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Møller, Christian Joost Holdflod, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, Zindovic, Igor, Åström, Daniel Oudin, Bjursten, Henrik, Oudin, Anna, Nozohoor, Shahab, Ahmad, Khalil, Tang, Mariann, Bjurbom, Markus, Hansson, Emma C., Jeppsson, Anders, Møller, Christian Joost Holdflod, Jormalainen, Miko, Juvonen, Tatu, Mennander, Ari, Olsen, Peter S., Olsson, Christian, Ahlsson, Anders, Pan, Emily, Raivio, Peter, Wickbom, Anders, Sjögren, Johan, Geirsson, Arnar, Gudbjartsson, Tomas, and Zindovic, Igor
- Abstract
We aimed to investigate a hypothesised association between daily mean temperature and the risk of surgery for acute type A aortic dissection (ATAAD). For the period of 1 January 2005 until 31 December 2019, we collected daily data on mean temperatures and date of 2995 operations for ATAAD at 10 Nordic cities included in the Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD) collaboration. Using a two-stage time-series approach, we investigated the association between hot and cold temperatures relative to the optimal temperature and the rate of ATAAD repair in the selected cities. The relative risks (RRs) of cold temperatures (<=-5 degrees C) and hot temperatures (>= 21 degrees C) compared to optimal temperature were 1.47 (95% CI: 0.72-2.99) and 1.43 (95% CI: 0.67-3.08), respectively. In line with previous studies, we observed increased risk at cold and hot temperatures. However, the observed associations were not statistically significant, thus only providing weak evidence of an association., Funding agency:Agreement for Medical Education and Research, Sweden
- Published
- 2022
- Full Text
- View/download PDF
25. Outcome After Surgery for Acute Type A Aortic Dissection With or Without Primary Tear Resection
- Author
-
Uimonen, Mikko, Olsson, Christian, Jeppsson, Anders, Geirsson, Arnar, Chemtob, Raphaelle, Khalil, Ahmad, Hjortdal, Vibeke, Hansson, Emma C., Nozohoor, Shahab, Zindovic, Igor, Gunn, Jarmo, Wickbom, Anders, Ahlsson, Anders, Gudbjartsson, Tomas, Mennander, Ari, Uimonen, Mikko, Olsson, Christian, Jeppsson, Anders, Geirsson, Arnar, Chemtob, Raphaelle, Khalil, Ahmad, Hjortdal, Vibeke, Hansson, Emma C., Nozohoor, Shahab, Zindovic, Igor, Gunn, Jarmo, Wickbom, Anders, Ahlsson, Anders, Gudbjartsson, Tomas, and Mennander, Ari
- Abstract
BACKGROUND: The outcome in patients after surgery for acute type A aortic dissection without replacement of the part of the aorta containing the primary tear is undefined. METHODS: Data of 1122 patients who underwent surgery for acute type A aortic dissection in 8 Nordic centers from January 2005 to December 2014 were retrospectively analyzed. The patients with primary tear location unfound, un-known, not confirmed, or not recorded (n = 243, 21.7%) were excluded from the analysis. The patients were divided into 2 groups according to whether the aortic reconstruction encompassed the portion of the primary tear (tear resected [TR] group, n = 730) or not (tear not resected [TNR] group, n = 149). The restricted mean survival time ratios adjusted for patient characteristics and surgical details between the groups were calculated for all-cause mortality and aortic reoperation-free survival. The median follow-up time was 2.57 (interquartile range, 0.53-5.30) years. RESULTS: For the majority of the patients in the TR group, the primary tear was located in the ascending aorta (83.6%). The reconstruction encompassed both the aortic root and the aortic arch in 7.4% in the TR group as compared with 0.7% in the TNR patients (P < .001). There were no significant differences in all-cause mortality (adjusted restricted mean survival time ratio, 1.01; 95% confidence interval, 0.92-1.12; P = .799) or reoperation-free survival (adjusted restricted mean survival time ratio, 0.98; 95% confidence interval, 0.95-1.02; P = .436) between the TR and TNR groups. CONCLUSIONS: Primary tear resection alone does not determine the midterm outcome after surgery for acute type A aortic dissection. (Ann Thorac Surg 2022;114:492-501) (c) 2022 by The Society of Thoracic Surgeons., Funding agencies:Competitive State Research Financing of the Expert Responsibility area of Tampere University HospitalFinnish Cultural Foundation from Pirkanmaa Regional FundThe Mats Kleberg Foundation, Stockholm, SwedenUniversity of Iceland Research FundLanspitali Research Fund
- Published
- 2022
- Full Text
- View/download PDF
26. Validation of two self-reported physical activity instruments against accelerometer data in patients undergoing lung cancer surgery
- Author
-
Jonsson, Marcus, Westerdahl, Elisabeth, Ahlsson, Anders, Hurtig-Wennlöf, Anita, Jonsson, Marcus, Westerdahl, Elisabeth, Ahlsson, Anders, and Hurtig-Wennlöf, Anita
- Abstract
INTRODUCTION: Finding ways of identifying patients with low levels of physical activity after lung cancer surgery would be beneficial when planning and providing interventions aimed at increasing physical activity. PURPOSE: To validate two self-reported physical activity instruments against accelerometer data. METHODS: Self-reported physical activity was assessed with the four category One Month Physical Activity Question (OMPAQ) and the International Physical Activity Questionnaire modified for the elderly (IPAQ-E). Objective measurement of physical activity was performed with the Actigraph GT3X+ accelerometer. All measurements were performed three months after lung cancer surgery. RESULTS: Three months after surgery, 83 patients provided complete physical activity measurements. There were statistically significant correlations between both of the self-reported physical activity assessed by OMPAQ (r = 0.54, p < .01) as well as IPAQ-E (r = 0.50, p < .01) and objectively measured physical activity (steps/day). The correlations were consistently stronger for the higher intensities of physical activity. Both instruments could identify patients not reaching the recommended levels of physical activity. CONCLUSION: Both OMPAQ and IPAQ-E give valid information on physical activity after lung cancer surgery, and might be used for screening patients in clinical settings. The OMPAQ provided stronger correlation and specificity than the IPAQ-E, and might be the preferred clinical choice.
- Published
- 2022
- Full Text
- View/download PDF
27. Medium-term survival after surgery for acute Type A aortic dissection is improving
- Author
-
Olsson, Christian, Ahlsson, Anders, Fuglsang, Simon, Geirsson, Arnar, Gunn, Jarmo, Hansson, Emma C, Hjortdal, Vibeke, Jarvela, Kati, Jeppsson, Anders, Mennander, Ari, Nozohoor, Shahab, Wickbom, Anders, Zindovic, Igor, and Gudbjartsson, Tomas
- Published
- 2017
- Full Text
- View/download PDF
28. Corrigendum to ‘2017 ESC/EACTS Guidelines for the management of valvular heart disease’ [Eur J Cardiothorac Surg 2017;52:616-664]†
- Author
-
Falk, Volkmar, Baumgartner, Helmut, Bax, Jeroen J., De Bonis, Michele, Hamm, Christian, Holm, Per Johan, Iung, Bernard, Lancellotti, Patrizio, Lansac, Emmanuel, Muñoz, Daniel Rodriguez, Rosenhek, Raphael, Sjögren, Johan, Mas, Pilar Tornos, Vahanian, Alec, Walther, Thomas, Wendler, Olaf, Windecker, Stephan, Zamorano, Jose Luis, Roffi, Marco, Alfieri, Ottavio, Agewall, Stefan, Ahlsson, Anders, Barbato, Emanuele, Bueno, Héctor, Collet, Jean-Philippe, Coman, Ioan Mircea, Czerny, Martin, Delgado, Victoria, Fitzsimons, Donna, Folliguet, Thierry, Gaemperli, Oliver, Habib, Gilbert, Harringer, Wolfgang, Haude, Michael, Hindricks, Gerhard, Katus, Hugo A., Knuuti, Juhani, Kolh, Philippe, Leclercq, Christophe, McDonagh, Theresa A., Piepoli, Massimo Francesco, Pierard, Luc A., Ponikowski, Piotr, Rosano, Giuseppe M.C., Ruschitzka, Frank, Shlyakhto, Evgeny, Simpson, Iain A., Sousa-Uva, Miguel, Stepinska, Janina, Tarantini, Giuseppe, Tchétché, Didier, and Aboyans, Victor
- Published
- 2017
- Full Text
- View/download PDF
29. 2017 ESC/EACTS Guidelines for the management of valvular heart disease
- Author
-
Falk, Volkmar, Baumgartner, Helmut, Bax, Jeroen J., De Bonis, Michele, Hamm, Christian, Holm, Per Johan, Iung, Bernard, Lancellotti, Patrizio, Lansac, Emmanuel, Muñoz, Daniel Rodriguez, Rosenhek, Raphael, Sjögren, Johan, Mas, Pilar Tornos, Vahanian, Alec, Walther, Thomas, Wendler, Olaf, Windecker, Stephan, Zamorano, Jose Luis, Roffi, Marco, Alfieri, Ottavio, Agewall, Stefan, Ahlsson, Anders, Barbato, Emanuele, Bueno, Héctor, Collet, Jean-Philippe, Coman, Ioan Mircea, Czerny, Martin, Delgado, Victoria, Fitzsimons, Donna, Folliguet, Thierry, Gaemperli, Oliver, Habib, Gilbert, Harringer, Wolfgang, Haude, Michael, Hindricks, Gerhard, Katus, Hugo A., Knuuti, Juhani, Kolh, Philippe, Leclercq, Christophe, McDonagh, Theresa A., Piepoli, Massimo Francesco, Pierard, Luc A., Ponikowski, Piotr, Rosano, Giuseppe M.C., Ruschitzka, Frank, Shlyakhto, Evgeny, Simpson, Iain A., Sousa-Uva, Miguel, Stepinska, Janina, Tarantini, Giuseppe, Tchétché, Didier, and Aboyans, Victor
- Published
- 2017
- Full Text
- View/download PDF
30. Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting
- Author
-
Taha, Amar, primary, Nielsen, Susanne J., additional, Franzén, Stefan, additional, Rezk, Mary, additional, Ahlsson, Anders, additional, Friberg, Leif, additional, Björck, Staffan, additional, Jeppsson, Anders, additional, and Bergfeldt, Lennart, additional
- Published
- 2022
- Full Text
- View/download PDF
31. Recombinant factor VIIa use in acute type A aortic dissection repair: A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection
- Author
-
Zindovic, Igor, Sjögren, Johan, Ahlsson, Anders, Bjursten, Henrik, Fuglsang, Simon, Geirsson, Arnar, Ingemansson, Richard, Hansson, Emma C., Mennander, Ari, Olsson, Christian, Pan, Emily, Ullén, Susann, Gudbjartsson, Tomas, and Nozohoor, Shahab
- Published
- 2017
- Full Text
- View/download PDF
32. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS
- Author
-
Kirchhof, Paulus, Benussi, Stefano, Kotecha, Dipak, Ahlsson, Anders, Atar, Dan, Casadei, Barbara, Castellá, Manuel, Diener, Hans-Christoph, Heidbuchel, Hein, Hendriks, Jeroen, Hindricks, Gerhard, Manolis, Antonis S., Oldgren, Jonas, Alexandru Popescu, Bogdan, Schotten, Ulrich, Van Putte, Bart, and Vardas, Panagiotis
- Published
- 2017
- Full Text
- View/download PDF
33. Validation of two self-reported physical activity instruments against accelerometer data in patients undergoing lung cancer surgery
- Author
-
Jonsson, Marcus, primary, Westerdahl, Elisabeth, additional, Ahlsson, Anders, additional, and Hurtig-Wennlöf, Anita, additional
- Published
- 2021
- Full Text
- View/download PDF
34. Major Bleeding of Transjugular Native Kidney Biopsies. A French Nationwide Cohort Study
- Author
-
Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis, Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan, La Meir, Mark, Lane, Deirdre, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory, Pinto, Fausto, Thomas, G Neil, Valgimigli, Marco, van Gelder, Isabelle, van Putte, Bart, Watkins, Caroline, Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, a John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry, Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Fitzsimons, Donna, Folliguet, Thierry, Gale, Chris, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo, Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil, Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia, Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto, Petersen, Steffen, Piccini, Jonathan, Popescu, Bogdan, Pürerfellner, Helmut, Richter, Dimitrios, Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate, Simpson, Iain, Shlyakhto, Evgeny, Sinner, Moritz, Steffel, Jan, Sousa-Uva, Miguel, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian, Neil Thomas, G, Delassi, Tahar, Sisakian, Hamayak, Chasnoits, Alexandr, Pauw, Michel De, Smajić, Elnur, Shalganov, Tchavdar, Avraamides, Panayiotis, Kautzner, Josef, Gerdes, Christian, Alaziz, Ahmad Abd, Kampus, Priit, Raatikainen, Pekka, Boveda, Serge, Papiashvili, Giorgi, Vassilikos, Vassilios, Csanádi, Zoltán, Arnar, David, Galvin, Joseph, Barsheshet, Alon, Caldarola, Pasquale, Rakisheva, Amina, Bytyçi, Ibadete, Kerimkulova, Alina, Kalejs, Oskars, Njeim, Mario, Puodziukynas, Aras, Groben, Laurent, Sammut, Mark, Grosu, Aurel, Boskovic, Aneta, Moustaghfir, Abdelhamid, Groot, Natasja De, Poposka, Lidija, Anfinsen, Ole-Gunnar, Mitkowski, Przemyslaw, Cavaco, Diogo Magalhães, Siliste, Calin, Mikhaylov, Evgeny, Bertelli, Luca, Kojic, Dejan, Hatala, Robert, Fras, Zlatko, Arribas, Fernando, Juhlin, Tord, Sticherling, Christian, Abid, Leila, Atar, Ilyas, Sychov, Oleg, Bates, Matthew, Zakirov, Nodir, Halimi, Jean-Michel, Gatault, Philippe, Longuet, Hélène, Barbet, Christelle, Goumard, Annabelle, Gueguen, Juliette, Goin, Nicolas, Sautenet, Bénédicte, Herbert, Julien, Bisson, Arnaud, Universität Leipzig [Leipzig], University of Belgrade [Belgrade], Leiden University Medical Center (LUMC), Uppsala University, Università degli Studi di Modena e Reggio Emilia, Colentina University Hospital, University of Medicine and Pharmacy 'Carol Davila' Bucharest (UMPCD), CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Éducation Éthique Santé EA 7505 (EES), Université de Tours (UT), National and Kapodistrian University of Athens (NKUA), Université d'Athènes (UOA), Attikon University Hospital, The Royal Melbourne Hospital, University of Liverpool, San Gerardo Hospital of Monza, Aalborg University [Denmark] (AAU), Universidade Nova de Lisboa = NOVA University Lisbon (NOVA), Faculdade de Medicina [Lisboa], Universidade de Lisboa (ULISBOA), Hospital de Santa Maria [Lisboa], Service de néphrologie et immunologie clinique [CHRU Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, and Université de Nantes (UN)-Université de Nantes (UN)
- Subjects
medicine.medical_specialty ,Framingham Risk Score ,Percutaneous ,business.industry ,medicine.medical_treatment ,kidney biopsy ,Retrospective cohort study ,Odds ratio ,Lower risk ,medicine.disease ,transjugular ,Nephrectomy ,Surgery ,[SHS]Humanities and Social Sciences ,bleeding score ,Hematoma ,percutaneous ,Nephrology ,Clinical Research ,medicine ,epidemiology ,business ,ComputingMilieux_MISCELLANEOUS ,Cohort study - Abstract
Introduction The risk of bleeding associated with transjugular kidney biopsies is unclear, and which patients are the best candidates for this route is unknown. Methods This was a retrospective cohort study comparing proportion of bleeding associated with transjugular versus percutaneous native kidney biopsies in all patients in France in the 2010–2019 period. Major bleeding at day 8 (i.e., blood transfusions, hemorrhage/hematoma, angiographic intervention, nephrectomy) and risk of death at day 30 were assessed, and we used a bleeding risk score initially developed for the percutaneous route. Results Our analysis included 60,331 patients (transjugular route: 5305; percutaneous route: 55,026 patients). The observed proportion of major bleeding varied widely (transjugular vs. percutaneous): 0.4% versus 0.5% for the lowest risk scores (0–4) to 19.1% versus 30.8% for the highest risk scores (≥35). Transjugular was more frequently used than percutaneous route (39% vs. 24%) when the risk score was ≥20 (15,133/60,331; 25% of all patients). Transjugular was associated with a lower risk of major bleeding than percutaneous route in multivariate analyses (odds ratio [OR]: 0.88 [0.78–0.99]), especially for scores ≥20 (OR: 0.83 [0.72–0.96], (i.e., 25% of patients). Major bleeding was associated with an increased risk of death both for transjugular (OR: 1.77 [1.00–3.14]) and percutaneous (OR: 1.80 [1.43–2.28]) routes. Conclusions The transjugular route is independently associated with a lower risk of bleeding than the percutaneous route, especially in high-risk patients identified by a preprocedure risk score ≥20 (i.e., 25% of patients). Major bleeding is associated with an increased risk of death for both routes., Graphical abstract
- Published
- 2021
35. Once after a full moon: acute type A aortic dissection and lunar phases
- Author
-
Bjursten, Henrik, primary, Oudin Åström, Daniel, additional, Nozohoor, Shahab, additional, Ahmad, Khalil, additional, Tang, Mariann, additional, Bjurbom, Markus, additional, Hansson, Emma C, additional, Jeppsson, Anders, additional, Joost Holdflod Møller, Christian, additional, Jormalainen, Miko, additional, Juvonen, Tatu, additional, Mennander, Ari, additional, Olsen, Peter S, additional, Olsson, Christian, additional, Ahlsson, Anders, additional, Oudin, Anna, additional, Pan, Emily, additional, Raivio, Peter, additional, Wickbom, Anders, additional, Sjögren, Johan, additional, Geirsson, Arnar, additional, Gudbjartsson, Tomas, additional, and Zindovic, Igor, additional
- Published
- 2021
- Full Text
- View/download PDF
36. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS):The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC
- Author
-
Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax , Jeroen J., Blomstro¨m-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E., Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan M., Meir, Mark La, Lane, Deirdre A, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y H, Pinto, Fausto J, Thomas, G Neil, Valgimigli, Marco, Gelder, Isabelle C Van, Putte, Bart P Van, Watkins, Caroline L, Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, A John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry J G M, Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Fitzsimons, Donna, Folliguet, Thierry, Gale, Chris P., Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo A, Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil S, Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluis, Mueller, Christian, Nagy, Klaudia V., Oldgren, Jonas, Pavlovic, Nikola, Pedretti, Roberto F.E., Petersen, Steffen Ellebæk, Piccini, Jonathan P, Popescu, Bogdan A, Pürerfellner, Helmut, Richter, Dimitrios J., Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate B, Simpson, Iain, Shlyakhto, Evgeny, Sinner, Moritz F, Steffel, Jan, Sousa-Uva, Miguel, Suwalski, Piotr, Svetlosak, Martin, and Touyz, Rhian M.
- Subjects
rhythm control ,left atrial ablation ,left atrial appendage occlusion ,AF surgery ,non-vitamin K antagonist oral anticoagulants ,screening ,Cardiology ,Anticoagulants ,Thoracic Surgery ,Guidelines ,upstream therapy ,stroke ,Europe ,vitamin K antagonists ,cardioversion ,antiarrhythmic drugs ,recommendations ,catheter ablation ,Atrial Fibrillation/diagnosis ,Humans ,atrial fibrillation ,ABC pathway ,anticoagulation ,pulmonary vein isolation ,rate control - Published
- 2021
37. Acute Kidney Injury After Acute Repair of Type A Aortic Dissection
- Author
-
Helgason, Dadi, Helgadottir, Solveig, Ahlsson, Anders, Gunn, Jarmo, Hjortdal, Vibeke, Hansson, Emma C, Jeppsson, Anders, Mennander, Ari, Nozohoor, Shahab, Zindovic, Igor, Olsson, Christian, Orri Ragnarsson, Stefan, Sigurdsson, Martin I, Geirsson, Arnar, Gudbjartsson, Tomas, Helgason, Dadi, Helgadottir, Solveig, Ahlsson, Anders, Gunn, Jarmo, Hjortdal, Vibeke, Hansson, Emma C, Jeppsson, Anders, Mennander, Ari, Nozohoor, Shahab, Zindovic, Igor, Olsson, Christian, Orri Ragnarsson, Stefan, Sigurdsson, Martin I, Geirsson, Arnar, and Gudbjartsson, Tomas
- Abstract
BACKGROUND: The aim of this study was to examine the incidence, risk factors, and outcomes of patients with acute kidney injury (AKI) after surgery for acute type A aortic dissection (ATAAD) using the Nordic Consortium for Acute Type A Aortic Dissection registry. METHODS: Patients who underwent ATAAD surgery at 8 Nordic centers from 2005 to 2014 were analyzed for AKI according to the RIFLE criteria. Patients who died intraoperatively, those who had missing baseline or postoperative serum creatinine, and patients on preoperative renal replacement therapy were excluded. RESULTS: AKI occurred in 382 of 941 patients (40.6%), and postoperative dialysis was required for 105 patients (11.0%). Renal malperfusion was present preoperatively in 42 patients (5.1%), of whom 69.0% developed postoperative AKI. In multivariable analysis patient-related predictors of AKI included age (per 10 years; odds ratio [OR], 1.30; 95% confidence interval [CI], 1.15-1.48), body mass index >30 kg/m2 (OR, 2.16; 95% CI, 1.51-3.09), renal malperfusion (OR, 4.39; 95% CI, 2.23-9.07), and other malperfusion (OR, 2.10; 95% CI, 1.55-2.86). Perioperative predictors were cardiopulmonary bypass time (per 10 minutes; OR, 1.04; 95% CI, 1.02-1.07) and red blood cell transfusion (OR per transfused unit, 1.08; 95% CI, 1.06-1.10). Rates of 30-day mortality were 17.0% in the AKI group compared with 6.6% in the non-AKI group (P < .001). In 30-day survivors AKI was an independent predictor of long-term mortality (hazard ratio, 1.86; 95% CI; 1.24-2.79). CONCLUSIONS: AKI is a common complication after surgery for ATAAD and independently predicts adverse long-term outcome. Of note one-third of patients presenting with renal malperfusion did not develop postoperative AKI, possibly because of restoration of renal blood flow with surgical repair. Mortality risk persists beyond the perioperative period, indicating that close clinical follow-up of these patients is required.
- Published
- 2021
- Full Text
- View/download PDF
38. Acute Kidney Injury After Acute Repair of Type A Aortic Dissection
- Author
-
Helgason, Dadi, primary, Helgadottir, Solveig, additional, Ahlsson, Anders, additional, Gunn, Jarmo, additional, Hjortdal, Vibeke, additional, Hansson, Emma C., additional, Jeppsson, Anders, additional, Mennander, Ari, additional, Nozohoor, Shahab, additional, Zindovic, Igor, additional, Olsson, Christian, additional, Ragnarsson, Stefan Orri, additional, Sigurdsson, Martin I., additional, Geirsson, Arnar, additional, and Gudbjartsson, Tomas, additional
- Published
- 2021
- Full Text
- View/download PDF
39. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement
- Author
-
Christersson, Christina, James, Stefan, Lindhagen, Lars, Ahlsson, Anders, Friberg, Örjan, Jeppsson, Anders, and Ståhle, Elisabeth
- Subjects
Kardiologi ,major bleeding ,haemorrhagic stroke ,Surgical biological aortic valve prosthesis ,ischemic stroke ,Cardiac and Cardiovascular Systems ,cardiovascular diseases ,thromboembolism ,antithrombotic treatment - Abstract
OBJECTIVES: To compare effectiveness of warfarin and antiplatelet exposure regarding both thrombotic and bleeding events, following surgical aortic valve replacement with a biological prosthesis(bioSAVR). METHODS: The study included all patients in Sweden undergoing a bioSAVR during 2008-2014 who were alive at discharge from the index hospital stay. Exposure was analysed and defined as postdischarge dispension of any antithrombotic pharmaceutical, updated at each following dispensions and categorised as single antiplatelet (SAPT), warfarin, warfarin combined with SAPT, dual antiplatelet (DAPT) or no antithrombotic treatment. Exposure to SAPT was used as comparator. Outcome events were all-cause mortality, ischaemic stroke, haemorrhagic stroke, any thromboembolism and major bleedings. We continuously updated adjustments for comorbidities with any indication for antithrombotic treatment by Cox regression analysis. RESULTS: We identified 9539 patients with bioSAVR (36.8% women) at median age of 73 years with a mean follow-up of 3.13 years. As compared with SAPT, warfarin alone was associated with a lower incidence of ischaemic stroke (HR 0.49, 95% CI 0.35 to 0.70) and any thromboembolism (HR 0.75, 95% CI 0.60 to 0.94) but with no difference in mortality (HR 0.94, 95% CI 0.78 to 1.13). The incidence of haemorrhagic stroke (HR 1.94, 95% CI 1.07 to 3.51) and major bleeding (HR 1.67, 95% CI 1.30 to 2.15) was higher during warfarin exposure. As compared with SAPT, DAPT was not associated with any difference in ischaemic stroke or any thromboembolism. Risk-benefit analyses demonstrated that 2.7 (95% CI 1.0 to 11.9) of the ischaemic stroke cases could potentially be avoided per every haemorrhagic stroke caused by warfarin exposure instead of SAPT during the first year. CONCLUSION: In patients discharged after bioSAVR, warfarin exposure as compared with SAPT exposure was associated with lower long-term risk of ischaemic stroke and thromboembolic events, and with a higher incidence of bleeding events but with similar mortality.
- Published
- 2020
40. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) : the Task Force for the diagnosis and management of atrialfibrillation of the European Society of Cardiology (ESC) : developed with the special contribution of the European HeartRhythm Association (EHRA) of the ESC
- Author
-
Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen J., Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E., Fauchier, Laurent, Petersen, Steffen E., Piccini, Jonathan P., Popescu, Bogdan A., Pürerfellner, Helmut, Richter, Dimitrios J., Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate B., Simpson, Iain A., Raatikainen, Pekka, Shlyakhto, Evgeny, Sinner, Moritz F., Steffel, Jan, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian M., Windecker, Stephan, Baigent, Colin, Collet, Jean-Philippe, Dean, Veronica, Boveda, Serge, Fitzsimons, Donna, Gale, Chris P., Grobbee, Diederick E., Halvorsen, Sigrun, Lung, Bernard, Jüni, Peter, Petronio, Anna Sonia, Sousa Uva, Miguel, Delassi, Tahar, Sisakian, Hamayak S., Papiashvili, Giorgi, Chasnoits, Alexandr, De Pauw, Michel, Smajić, Elnur, Shalganov, Tchavdar, Avraamides, Panayiotis, Kautzner, Josef, Gerdes, Christian, Alaziz, Ahmad Abd, Kampus, Priit, Vassilikos, Vassilios P., Csanádi, Zoltán, Arnar, David O., Galvin, Joseph, Barsheshet, Alon, Caldarola, Pasquale, Rakisheva, Amina, Filippatos, Gerasimos, Bytyçi, Ibadete, Kerimkulova, Alina, Kalejs, Oskars, Njeim, Mario, Puodziukynas, Aras, Groben, Laurent, Sammut, Mark A., Grosu, Aurel, Boskovic, Aneta, Moustaghfir, Abdelhamid, Kalman, Jonathan M., de Groot, Natasja, Poposka, Lidija, Anfinsen, Ole-Gunnar, Mitkowski, Przemyslaw P., Cavaco, Diogo, Siliste, Calin, Mikhaylov, Evgeny N., Bertelli, Luca, Kojic, Dejan, Hatala, Robert, La Meir, Mark, Fras, Zlatko, Arribas, Fernando, Juhlin, Tord, Sticherling, Christian, Abid, Leila, Atar, Ilyas, Sychov, Oleg, Bates, Matthew G. D., Zakirov, Nodir U., Lane, Deirdre A., Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y. H., Pinto, Fausto J., Thomas, G. Neil, Valgimigli, Marco, Van Gelder, Isabelle C., Van Putte, Bart P., Watkins, Caroline L., Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, A. John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry J. G. M., Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Folliguet, Thierry, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo A., Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil S., Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia V., Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto F. E., and Repositório da Universidade de Lisboa
- Subjects
Rate control ,AF surgery ,Guidelines ,Upstream therapy ,Recommendations ,Left atrial appendage occlusion ,Atrial fibrillation ,Pulmonary vein isolation ,Left atrial ablation ,Antiarrhythmic drugs ,Cardioversion ,Stroke ,Anticoagulation ,Vitamin K antagonists ,Screening ,Non-vitamin K antagonist oral anticoagulants ,Rhythm control ,Catheter ablation ,ABC pathway - Abstract
© 2020 European Society of Cardiology. All rights reserved., Atrial fibrillation (AF) poses significant burden to patients, physicians, and healthcare systems globally. Substantial research efforts and resources are being directed towards gaining detailed information about the mechanisms underlying AF, its natural course and effective treatments (see also the ESC Textbook of Cardiovascular Medicine: CardioMed) and new evidence is continuously generated and published. The complexity of AF requires a multifaceted, holistic, and multidisciplinary approach to the management of AF patients, with their active involvement in partnership with clinicians. Streamlining the care of patients with AF in daily clinical practice is a challenging but essential requirement for effective management of AF. In recent years, substantial progress has been made in the detection of AF and its management, and new evidence is timely integrated in this third edition of the ESC guidelines on AF. The 2016 ESC AF Guidelines introduced the concept of the five domains to facilitate an integrated structured approach to AF care and promote consistent, guideline-adherent management for all patients. The Atrial Fibrillation Better Care (ABC) approach in the 2020 ESC AF Guidelines is a continuum of this approach, with the goal to further improve the structured management of AF patients, promote patient values, and finally improve patient outcomes.
- Published
- 2020
41. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- Author
-
Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen J, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E, Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan M, La Meir, Mark, Lane, Deirdre A, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y H, Pinto, Fausto J, Thomas, G Neil, Valgimigli, Marco, Van Gelder, Isabelle C, Van Putte, Bart P, Watkins, Caroline Leigh, Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, A John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry J G M, Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Fitzsimons, Donna, Folliguet, Thierry, Gale, Chris P, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo A, Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil S, Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia V, Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto F E, Petersen, Steffen E, Piccini, Jonathan P, Popescu, Bogdan A, Pürerfellner, Helmut, Richter, Dimitrios J, Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate B, Simpson, Iain A, Shlyakhto, Evgeny, Sinner, Moritz F, Steffel, Jan, Sousa-Uva, Miguel, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian M, Neil Thomas, G, Watkins, Caroline L, Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen J, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E, Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan M, La Meir, Mark, Lane, Deirdre A, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y H, Pinto, Fausto J, Thomas, G Neil, Valgimigli, Marco, Van Gelder, Isabelle C, Van Putte, Bart P, Watkins, Caroline Leigh, Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, A John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry J G M, Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Fitzsimons, Donna, Folliguet, Thierry, Gale, Chris P, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo A, Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil S, Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia V, Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto F E, Petersen, Steffen E, Piccini, Jonathan P, Popescu, Bogdan A, Pürerfellner, Helmut, Richter, Dimitrios J, Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate B, Simpson, Iain A, Shlyakhto, Evgeny, Sinner, Moritz F, Steffel, Jan, Sousa-Uva, Miguel, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian M, Neil Thomas, G, and Watkins, Caroline L
- Published
- 2020
42. Stroke in acute type A aortic dissection : the Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD)
- Author
-
Chemtob, Raphaelle A., Fuglsang, Simon, Geirsson, Arnar, Ahlsson, Anders, Olsson, Christian, Gunn, Jarmo, Ahmad, Khalil, Hansson, Emma C., Pan, Emily, Arnadottir, Linda O., Mennander, Ari, Nozohoor, Shahab, Wickbom, Anders, Zindovic, Igor, Pivodic, Aldina, Jeppsson, Anders, Hjortdal, Vibeke, Gudbjartsson, Tomas, Chemtob, Raphaelle A., Fuglsang, Simon, Geirsson, Arnar, Ahlsson, Anders, Olsson, Christian, Gunn, Jarmo, Ahmad, Khalil, Hansson, Emma C., Pan, Emily, Arnadottir, Linda O., Mennander, Ari, Nozohoor, Shahab, Wickbom, Anders, Zindovic, Igor, Pivodic, Aldina, Jeppsson, Anders, Hjortdal, Vibeke, and Gudbjartsson, Tomas
- Abstract
OBJECTIVES: Stroke is a serious complication in patients with acute type A aortic dissection (ATAAD). Previous studies investigating stroke in ATAAD patients have been limited by small cohorts and have shown diverging results. We sought to identify risk factors for stroke and to evaluate the effect of stroke on outcomes in surgical ATAAD patients. METHODS: The Nordic Consortium for Acute Type A Aortic Dissection database included patients operated for ATAAD at 8 Scandinavian Hospitals between 2005 and 2014. RESULTS: Stroke occurred in 177 (15.7%) out of 1128 patients. Patients with stroke presented more frequently with cerebral malperfusion (20.6% vs 6.3%, P < 0.001), syncope (30.6% vs 17.6%, P < 0.001), cardiogenic shock (33.1% vs 20.7%, P < 0.001) and pericardial tamponade (25.9% vs 14.7%, P < 0.001) and more often underwent total aortic arch replacement (10.7% vs 4.7%, P = 0.016), compared to patients without stroke. In the 86 patients presenting with cerebral malperfusion, 38.4% developed stroke. Thirty-day and 5-year mortality in patients with and without stroke were 27.1% vs 13.6% and 42.9% vs 25.6%, respectively. Stroke was an independent predictor of early- [odds ratio 2.02, 95% confidence interval (CI) 1.34-3.05; P < 0.001] and midterm mortality (hazard ratio 1.68, 95% CI 1.27-2.23; P < 0.001). CONCLUSIONS: Stroke in ATAAD patients is associated with increased early- and midterm mortality. Preoperative cerebral malperfusion and impaired haemodynamics, as well as total aortic arch replacement, were more frequent among patients who developed stroke. Importantly, a large proportion of patients presenting with cerebral malperfusion did not develop a permanent stroke, indicating that signs of cerebral malperfusion should not be considered a contraindication for surgery.
- Published
- 2020
- Full Text
- View/download PDF
43. New‐Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Outcome: A Population‐Based Nationwide Study From the SWEDEHEART Registry
- Author
-
Taha, Amar, primary, Nielsen, Susanne J., additional, Bergfeldt, Lennart, additional, Ahlsson, Anders, additional, Friberg, Leif, additional, Björck, Staffan, additional, Franzén, Stefan, additional, and Jeppsson, Anders, additional
- Published
- 2021
- Full Text
- View/download PDF
44. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
- Author
-
Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen J, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E, Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan M, La Meir, Mark, Lane, Deirdre A, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y H, Pinto, Fausto J, Thomas, G Neil, Valgimigli, Marco, Van Gelder, Isabelle C, Van Putte, Bart P, Watkins, Caroline L, Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, A John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry J G M, Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Fitzsimons, Donna, Folliguet, Thierry, Gale, Chris P, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo A, Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil S, Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia V, Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto F E, Petersen, Steffen E, Piccini, Jonathan P, Popescu, Bogdan A, Pürerfellner, Helmut, Richter, Dimitrios J, Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate B, Simpson, Iain A, Shlyakhto, Evgeny, Sinner, Moritz F, Steffel, Jan, Sousa-Uva, Miguel, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian M, Neil Thomas, G, CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Cardiovascular Centre (CVC), Surgical clinical sciences, and Cardiac Surgery
- Subjects
left atrial ablation ,left atrial appendage occlusion ,AF surgery ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Management of atrial fibrillation ,030204 cardiovascular system & hematology ,Cardioversion ,VITAMIN-K ANTAGONIST ,surgery ,chemistry.chemical_compound ,0302 clinical medicine ,cardioversion ,Edoxaban ,QUALITY-OF-LIFE ,antiarrhythmic drugs ,OBSTRUCTIVE SLEEP-APNEA ,catheter ablation ,RADIOFREQUENCY CATHETER ABLATION ,Medicine ,atrial fibrillation ,030212 general & internal medicine ,anticoagulation ,reproductive and urinary physiology ,ComputingMilieux_MISCELLANEOUS ,pulmonary vein isolation ,0303 health sciences ,rhythm control ,EACTS ,HEART RHYTHM SOCIETY ,recommendations ,Atrial fibrillation ,General Medicine ,non-Vitamin K antagonist oral anticoagulants ,Vitamin K antagonist ,PULMONARY-VEIN ISOLATION ,stroke ,3. Good health ,2020 ESC Guidelines ,Dronedarone ,vitamin K antagonists ,Cardiothoracic surgery ,Cardio-Thoracic Surgery ,embryonic structures ,DIRECT ORAL ANTICOAGULANTS ,cardiovascular system ,Cardiology ,Dose reduction ,biological phenomena, cell phenomena, and immunity ,Cardiology and Cardiovascular Medicine ,medicine.drug ,Quinidine ,medicine.medical_specialty ,medicine.drug_class ,non-vitamin K antagonist oral anticoagulants ,PERCUTANEOUS CORONARY INTERVENTION ,Renal function ,macromolecular substances ,ABC pathway ,Guidelines ,rate control ,screening ,upstream therapy ,Vitamin K antagonists ,B700 ,03 medical and health sciences ,Internal medicine ,Diseases of the circulatory (Cardiovascular) system ,cardiovascular diseases ,030304 developmental biology ,urogenital system ,business.industry ,medicine.disease ,TRANSIENT ISCHEMIC ATTACK ,ANTIARRHYTHMIC-DRUG-THERAPY ,chemistry ,030228 respiratory system ,Concomitant ,RC666-701 ,business - Abstract
Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It should also read "60 mg"instead of "60 mg (use with caution in 'supranormal' renal function)."In the above-indicated cell, a footnote has also been added to state: "Edoxaban should be used in patients with high creatinine clearance only after a careful evaluation of the individual thromboembolic and bleeding risk."Supplementary Table 9, column 'Edoxaban', row 'Dose reduction in selected patients' (page 16). The cell should read "Edoxaban 60 mg reduced to 30 mg once daily if any of the following: creatinine clearance 15-50 mL/min, body weight
- Published
- 2021
45. Stroke in acute type A aortic dissection: the Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD)
- Author
-
Chemtob, Raphaelle A, primary, Fuglsang, Simon, additional, Geirsson, Arnar, additional, Ahlsson, Anders, additional, Olsson, Christian, additional, Gunn, Jarmo, additional, Ahmad, Khalil, additional, Hansson, Emma C, additional, Pan, Emily, additional, Arnadottir, Linda O, additional, Mennander, Ari, additional, Nozohoor, Shahab, additional, Wickbom, Anders, additional, Zindovic, Igor, additional, Pivodic, Aldina, additional, Jeppsson, Anders, additional, Hjortdal, Vibeke, additional, and Gudbjartsson, Tomas, additional
- Published
- 2020
- Full Text
- View/download PDF
46. Why change? Lessons in leadership from the COVID-19 pandemic
- Author
-
Ahlsson, Anders, primary
- Published
- 2020
- Full Text
- View/download PDF
47. 2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)
- Author
-
Neumann, Franz-Josef, Sousa-Uva, Miguel, Ahlsson, Anders, Alfonso, Fernando, Banning, Adrian P, Benedetto, Umberto, Byrne, Robert A, Collet, Jean-Philippe, Falk, Volkmar, Head, Stuart J, Jüni, Peter, Kastrati, Adnan, Koller, Akos, Kristensen, Steen D, Niebauer, Josef, Richter, Dimitrios J, Seferovic', Petar M, Sibbing, Dirk, Stefanini, Giulio G, Windecker, Stephan, Yadav, Rashmi, and Zembala, Michael O
- Published
- 2019
48. Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome
- Author
-
Batra, Gorav, Ahlsson, Anders, Lindahl, Bertil, Lindhagen, Lars, Wickbom, Anders, Oldgren, Jonas, Batra, Gorav, Ahlsson, Anders, Lindahl, Bertil, Lindhagen, Lars, Wickbom, Anders, and Oldgren, Jonas
- Abstract
Background: The aim was to determine the association between atrial fibrillation (AF) and outcome in patients undergoing coronary artery bypass grafting (CABG). Methods: All patients undergoing CABG between January 2010 and June 2013 were identified in the Swedish Heart Surgery Registry. Outcomes studied were all-cause mortality, cardiovascular mortality, myocardial infarction, congestive heart failure, ischemic stroke, and recurrent AF. Patients with history of AF prior to surgery (preoperative AF) and patients without history of AF but with AF episodes post-surgery (postoperative AF) were compared to patients with no AF using adjusted Cox regression models. Results: Among 9,107 identified patients, 8.1% (n = 737) had preoperative AF, and 25.1% (n = 2,290) had postoperative AF. Median follow-up was 2.2 years. Compared to no AF, preoperative AF was associated with higher risk of all-cause mortality, adjusted hazard ratio with 95% confidence interval (HR) 1.76 (1.33-2.33); cardiovascular mortality, HR 2.43 (1.68-3.50); and congestive heart failure, HR 2.21 (1.72-2.84). Postoperative AF was associated with risk of all-cause mortality, HR 1.27 (1.01-1.60); cardiovascular mortality, HR 1.52 (1.10-2.11); congestive heart failure, HR 1.47 (1.18-1.83); and recurrent AF, HR 4.38 (2.46-7.78). No significant association was observed between pre- or postoperative AF and risk for myocardial infarction and ischemic stroke. Conclusions: Approximately 1 in 3 patients undergoing CABG had pre- or postoperative AF. Patients with pre- or postoperative AF were at higher risk of all-cause mortality, cardiovascular mortality, and congestive heart failure, but not of myocardial infarction or ischemic stroke. Postoperative AF was associated with higher risk of recurrent AF.
- Published
- 2019
- Full Text
- View/download PDF
49. Preoperative dual antiplatelet therapy increases bleeding and transfusions but not mortality in acute aortic dissection type A repair
- Author
-
Hansson, Emma C, Geirsson, Arnar, Hjortdal, Vibeke, Mennander, Ari, Olsson, Christian, Gunn, Jarmo, Zindovic, Igor, Ahlsson, Anders, Nozohoor, Shahab, Chemtob, Raphaelle A, Pivodic, Aldina, Gudbjartsson, Tomas, Jeppsson, Anders, Hansson, Emma C, Geirsson, Arnar, Hjortdal, Vibeke, Mennander, Ari, Olsson, Christian, Gunn, Jarmo, Zindovic, Igor, Ahlsson, Anders, Nozohoor, Shahab, Chemtob, Raphaelle A, Pivodic, Aldina, Gudbjartsson, Tomas, and Jeppsson, Anders
- Abstract
OBJECTIVES: Acute aortic dissection type A is a life-threatening condition, warranting immediate surgery. Presentation with sudden chest pain confers a risk of misdiagnosis as acute coronary syndrome resulting in subsequent potent antiplatelet treatment. We investigated the impact of dual antiplatelet therapy (DAPT) on bleeding and mortality using the Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD) database.METHODS: The NORCAAD database is a retrospective multicentre database where 119 of 1141 patients (10.4%) had DAPT with ASA + clopidogrel (n = 108) or ASA + ticagrelor (n = 11) before surgery. The incidence of major bleeding and 30-day mortality was compared between DAPT and non-DAPT patients with logistic regression models before and after propensity score matching.RESULTS: Before matching, 51.3% of DAPT patients had major bleeding when compared to 37.7% of non-DAPT patients (P = 0.0049). DAPT patients received more transfusions of red blood cells [median 8 U (Q1-Q3 4-15) vs 5.5 U (2-11), P < 0.0001] and platelets [4 U (2-8) vs 2 U (1-4), P = 0.0001]. Crude 30-day mortality was 19.3% vs 17.0% (P = 0.60). After matching, major bleeding remained significantly more common in DAPT patients, 51.3% vs 39.3% [odds ratio (OR) 1.63, 95% confidence interval (CI) 1.05-2.51; P = 0.028], but mortality did not significantly differ (OR 0.88, 95% CI 0.51-1.50; P = 0.63). Major bleeding was associated with increased 30-day mortality (adjusted OR 2.44, 95% CI 1.72-3.46; P < 0.0001).CONCLUSIONS: DAPT prior to acute aortic dissection repair was associated with increased bleeding and transfusions but not with mortality. Major bleeding per se was associated with a significantly increased mortality. Correct diagnosis is important to avoid DAPT and thereby reduce bleeding risk, but ongoing DAPT should not delay surgery.
- Published
- 2019
50. Malperfusion in acute type A aortic dissection:An update from the Nordic Consortium for Acute Type A Aortic Dissection
- Author
-
Zindovic, Igor, Gudbjartsson, Tomas, Ahlsson, Anders, Fuglsang, Simon, Gunn, Jarmo, Hansson, Emma C, Hjortdal, Vibeke, Järvelä, Kati, Jeppsson, Anders, Mennander, Ari, Olsson, Christian, Pan, Emily, Sjögren, Johan, Wickbom, Anders, Geirsson, Arnar, Nozohoor, Shahab, Zindovic, Igor, Gudbjartsson, Tomas, Ahlsson, Anders, Fuglsang, Simon, Gunn, Jarmo, Hansson, Emma C, Hjortdal, Vibeke, Järvelä, Kati, Jeppsson, Anders, Mennander, Ari, Olsson, Christian, Pan, Emily, Sjögren, Johan, Wickbom, Anders, Geirsson, Arnar, and Nozohoor, Shahab
- Abstract
OBJECTIVES: To evaluate the effect of preoperative malperfusion on 30-day and late mortality and postoperative complications using data from the Nordic Consortium for Acute Type A Aortic Dissection (ATAAD) registry.METHODS: We studied 1159 patients who underwent ATAAD surgery between January 2005 and December 2014 at 8 Nordic centers. Multivariable logistic and Cox regression analyses were performed to identify independent predictors of 30-day and late mortality.RESULTS: Preoperative malperfusion was identified in 381 of 1159 patients (33%) who underwent ATAAD surgery. Thirty-day mortality was 28.9% in patients with preoperative malperfusion and 12.1% in those without. Independent predictors of 30-day mortality included any malperfusion (odds ratio, 2.76; 95% confidence interval [CI], 1.94-3.93), cardiac malperfusion (odds ratio, 2.37; 95% CI, 1.34-4.17), renal malperfusion (odds ratio, 2.38; 95% CI, 1.23-4.61) and peripheral malperfusion (odds ratio, 1.95; 95% CI, 1.26-3.01). Any malperfusion (hazard ratio, 1.72; 95% CI, 1.21-2.43), cardiac malperfusion (hazard ratio, 1.89; 95% CI, 1.24-2.87) and gastrointestinal malperfusion (hazard ratio, 2.25; 95% CI, 1.18-4.26) were predictors of late mortality. Malperfusion was associated with significantly poorer survival at 1, 3, and 5 years (95.0% ± 0.9% vs 88.7% ± 1.9%, 90.1% ± 1.3% vs 84.0% ± 2.4%, and 85.4% ± 1.7% vs 80.8% ± 2.7%; log rank P = .009).CONCLUSIONS: Malperfusion has a significant influence on early and late outcomes in ATAAD surgery. Management of preoperative malperfusion remains a major challenge in reducing mortality associated with surgical treatment of ATAAD.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.